Researchers have developed a chemovaccination strategy that uses mosquito-delivered malaria parasites paired with antimalarial drugs to induce potent, durable immunity in mice. This approach blocks parasite development at a critical stage, preventing disease and reinforcing immune response through subsequent bites, offering a new preventive measure against one of the world’s deadliest infectious diseases.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



